A cross-sectional study of real life data of HCV from Turkey south region.
暂无分享,去创建一个
B. Kara | B. M. Suntur | Taylan Bozok | H. Eker | Nevzat Unal | Hava Kaya
[1] N. Örmeci,et al. Evaluation of Risk Factors Associated with HBsAg and Anti-HCV Seropositivity: Results of a Nationwide Population Based Epidemiological Survey Study in Turkey , 2019, Mediterranean Journal of Infection Microbes and Antimicrobials.
[2] T. Hallett,et al. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model , 2019, The Lancet.
[3] N. Terrault. Hepatitis C elimination: challenges with under-diagnosis and under-treatment , 2019, F1000Research.
[4] J. Leung,et al. Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs , 2018, Addiction.
[5] G. Dore,et al. Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis. , 2018, The lancet. Gastroenterology & hepatology.
[6] R. Taherkhani,et al. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges , 2017, World journal of hepatology.
[7] J. Rockstroh,et al. Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there? , 2017, Journal of the International AIDS Society.
[8] M. Çetin,et al. Hepatitis C infection and other drug‐related harms among inpatients who injected drugs in Turkey , 2017, Journal of viral hepatitis.
[9] Ibrahim Abubakar,et al. Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure , 2017, Scientific Reports.
[10] Gamal Esmat,et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. , 2017, The lancet. Gastroenterology & hepatology.
[11] A. Mangia,et al. Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] A. Petruzziello,et al. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes , 2016, World journal of gastroenterology.
[13] D. De Angelis,et al. Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence , 2015, Current opinion in infectious diseases.
[14] U. Akarca,et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] Jason Grebely,et al. Mixed HCV infection and reinfection in people who inject drugs—impact on therapy , 2015, Nature Reviews Gastroenterology &Hepatology.
[16] Matt Anderson,et al. European Monitoring Centre for Drugs and Drug Addiction , 2014 .
[17] O. Ergonul,et al. Hepatitis C prevalence in Turkey: estimation through meta-analysis , 2014 .
[18] G. Esmat,et al. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm , 2014, Journal of viral hepatitis.
[19] Y. Taşova,et al. Changing Epidemiology of Chronic Hepatitis C in Adana , 2014 .
[20] M. Demir,et al. Hepatitis C virus genotypes in Adana and Antakya regions of Turkey. , 2014, Turkish journal of medical sciences.
[21] Louisa Degenhardt,et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.
[22] S. Sauleda,et al. The changing epidemiology of hepatitis C virus infection in Europe. , 2008, Journal of hepatology.
[23] S. Ramia,et al. Distribution of hepatitis C virus genotypes in the Middle East. , 2006, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[24] K. Demır,et al. Risk Factors for the Transmission of Hepatitis C Virus Infection in the Turkish Population , 2006, Digestive Diseases and Sciences.
[25] H. Senturk,et al. Hepatitis C Virus Risk Factors in the Turkish Community , 2005, Digestive Diseases and Sciences.